tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Income Statement

Compare
558 Followers

Elevation Oncology Income Statement

Last quarter (Q3 2024), Elevation Oncology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Elevation Oncology's net income was $-12.88M. See Elevation Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -39.00K$ -27.00K$ -18.00K$ -15.00K$ 0.00
Operating Expenses
$ 45.45M$ 94.55M$ 32.05M$ 17.28M$ 5.88M
Depreciation and Amortization
$ 39.00K$ 27.00K$ 18.00K$ 15.00K$ 3.57M
EBITDA
$ -41.47M$ -94.52M$ -32.03M$ -17.25M$ -5.88M
Operating Income
$ -45.45M$ -94.55M$ -32.05M$ -17.28M$ -5.88M
Other Income/Expenses
$ -229.00K$ -506.00K$ 7.00K$ 11.00K$ 0.00
Pretax Income
$ -45.67M$ -95.06M$ -32.04M$ -17.27M$ -5.88M
Net Income
$ -45.70M$ -95.08M$ -32.04M$ -17.27M$ -5.88M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.34$ -4.09$ -1.38$ -0.73$ -0.25
Diluted EPS
$ -1.34$ -4.09$ -1.38$ -0.73$ -0.25
Weighted Average Shares Outstanding
34.08M 23.27M 23.21M 23.76M 23.76M
Weighted Average Shares Outstanding (Diluted)
34.08M 23.27M 23.21M 23.76M 23.76M
Currency in USD

Elevation Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis